Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma-Reference-Cited by-同舟云学术

Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma

Published:2017-07-28 Issue:31 Volume:9 Page:25887-25904
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Wu Victoria M.¹²,Mickens Jarrett²,Uskoković Vuk¹²^ORCID

Affiliation:

1. Advanced Materials and Nanobiotechnology Laboratory, Department of Biomedical and Pharmaceutical Sciences, Center for Targeted Drug Delivery, Chapman University School of Pharmacy, 9401 Jeronimo Road, Irvine, California 92618-1908, United States

2. Advanced Materials and Nanobiotechnology Laboratory, Department of Bioengineering, University of Illinois, Chicago, Illinois 60607-7052, United States

Funder

National Institute of Dental and Craniofacial Research

University of Illinois at Chicago

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.7b08108

Reference73 articles.

1. Non-metastatic osteosarcoma of the extremities in children aged 5 years or younger

2. Prognostic factors and outcomes for osteosarcoma: An international collaboration